Clinical Trial Update: Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating oral S-1 plus gemcitabine in metastatic pancreatic cancer; the trial is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: SUSPENDED